RUBINSTEIN JULIE bought ADPT
April 9, 2026 · Form 4 insider transaction
RUBINSTEIN JULIE bought 14,722 shares of Adaptive Biotechnologies Corporation at $7.27 per share, a transaction worth $107.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,722
Price
$7.27
Total value
$107.0K
InsiderRUBINSTEIN JULIE
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 9, 2026
Filing dateApril 13, 2026
Shares owned after448,910
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.